1154 Participants Needed

Home Care Improvement Intervention for Heart Failure

(I-TRANSFER-HF Trial)

Recruiting at 1 trial location
MR
Overseen ByMadeline R Sterling, MD, MPH, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study is trying to improve the hospital-to-home transition for people with heart failure who receive home care services. The study will test an intervention called I-TRANSFER-HF, which differs from usual care by combining early home health nurse visits and outpatient medical appointments. The study is interested in two questions: 1. Is I-TRANSFER-HF better than usual care at preventing heart failure patients from returning to the hospital within 30 days? 2. Are there parts of I-TRANSFER-HF that are easy or hard to implement in the real world? The researchers will answer these questions by testing the intervention among pairs of hospitals and home health agencies across the country. During the study, the hospital-agency pairs will be asked to implement I-TRANSFER-HF. The researchers will then compare the results from before and after I-TRANSFER-HF was adopted. They will also interview people from these hospitals and agencies to see how I-TRANSFER-HF is being implemented under real-world conditions.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on improving care transitions rather than changing medication regimens.

What data supports the effectiveness of the treatment I-TRANSFER-HF for heart failure patients?

Research shows that home health interventions, like CareNavRN, can improve heart failure patients' knowledge, self-care, and quality of life, and may reduce hospital readmissions. Although the results were not statistically significant, they suggest that such interventions could be beneficial during the transition from hospital to home.12345

Is the Home Care Improvement Intervention for Heart Failure safe for humans?

The available research focuses on the effectiveness of transitional care services for heart failure patients but does not provide specific safety data for the Home Care Improvement Intervention or its related programs.25678

What makes the I-TRANSFER-HF treatment unique for heart failure patients?

The I-TRANSFER-HF treatment is unique because it focuses on improving the transition from hospital to home for heart failure patients by using specially trained home health nurses who visit patients weekly for four weeks. This approach aims to reduce hospital readmissions and improve patients' knowledge, self-care, and quality of life, which is different from standard treatments that may not provide such personalized, ongoing support at home.236910

Research Team

MR

Madeline R Sterling, MD, MPH, MS

Principal Investigator

Weill Medical College of Cornell University

Eligibility Criteria

This trial is for adults hospitalized with heart failure transitioning from certain hospitals to home health care (HHC) services. It includes healthcare professionals involved in this transition process at participating hospital-HHC pairs. Excluded are patients discharged elsewhere, on dialysis, or with left ventricular devices.

Inclusion Criteria

I am a healthcare professional working on transitioning heart failure patients from hospital to home care.
Adults who are hospitalized for heart failure and are moved from the hospital to a partnering home health care agency during the study.

Exclusion Criteria

I am not a healthcare professional managing heart failure patient transitions from hospital to home care.
I was hospitalized for heart failure and have been discharged to a facility or home without home health care.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Implementation of I-TRANSFER-HF, combining early home health nurse visits and outpatient medical appointments

12 months
Regular visits as per intervention protocol

Follow-up

Participants are monitored for safety and effectiveness after intervention

30 days

Treatment Details

Interventions

  • I-TRANSFER-HF
Trial Overview The I-TRANSFER-HF intervention aims to improve the transition from hospital to home care for heart failure patients. The study compares outcomes before and after its implementation and assesses how well it works in real-world settings by preventing rehospitalization within 30 days.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: I-TRANSFER-HFExperimental Treatment1 Intervention
This is a 1-year long intervention period when I-TRANSFER-HF is in operation.
Group II: Standard of Care (usual care)Active Control1 Intervention
This is a baseline period of usual care (UC) with no intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Johns Hopkins University

Collaborator

Trials
2,366
Recruited
15,160,000+

University of Colorado, Denver

Collaborator

Trials
1,842
Recruited
3,028,000+

NYU Langone Health

Collaborator

Trials
1,431
Recruited
838,000+

University of California, San Diego

Collaborator

Trials
1,215
Recruited
1,593,000+

Findings from Research

In a study involving 2494 adults hospitalized for heart failure, a patient-centered transitional care model did not significantly reduce hospital readmissions or emergency department visits compared to usual care.
However, the intervention improved patients' preparedness for discharge and quality of transition, indicating benefits in patient experience despite no change in clinical outcomes.
Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure: The PACT-HF Randomized Clinical Trial.Van Spall, HGC., Lee, SF., Xie, F., et al.[2020]
A project in a São Paulo cardiology hospital showed that compliance with best practices for transitional care in heart failure patients improved significantly after implementing targeted strategies, including nurse training and revised discharge procedures.
Before the intervention, compliance was zero for five out of six criteria, but after the intervention, compliance reached 100% for those criteria, demonstrating the effectiveness of the implemented strategies.
Transitional care from the hospital to the home in heart failure: implementation of best practices.Nakahara-Melo, M., Conceição, APD., Cruz, DALMD., et al.[2021]
The CareNavRN™ intervention, involving specialized home health nurse visits for 4 weeks, showed a reduction in 30-day hospital readmission rates for heart failure patients, with 16% in the intervention group compared to 29% in the control group, although the results were not statistically significant due to small sample size.
Participants in the intervention group demonstrated significant improvements in heart failure knowledge, self-care confidence, and quality of life, indicating that CareNavRN™ may enhance patient outcomes during the transition from hospital to home.
Testing the Effect of a Home Health Heart Failure Intervention on Hospital Readmissions, Heart Failure Knowledge, Self-Care, and Quality of Life.Leavitt, MA., Hain, DJ., Keller, KB., et al.[2021]

References

Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure: The PACT-HF Randomized Clinical Trial. [2020]
Transitional care from the hospital to the home in heart failure: implementation of best practices. [2021]
Testing the Effect of a Home Health Heart Failure Intervention on Hospital Readmissions, Heart Failure Knowledge, Self-Care, and Quality of Life. [2021]
PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France. [2022]
Knowledge to action: Rationale and design of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) stepped wedge cluster randomized trial. [2019]
Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis. [2022]
Transitions of care in heart failure: a scientific statement from the American Heart Association. [2022]
Best practices for heart failure: a focused review. [2016]
Variability in Implementation of Interventions Aimed at Reducing Readmissions Among Patients With Heart Failure: A Survey of Teaching Hospitals. [2018]
10.United Statespubmed.ncbi.nlm.nih.gov
Effects of nurse-led transitional care interventions for patients with heart failure on healthcare utilization: A meta-analysis of randomized controlled trials. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security